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ABSTRACT
Huntington’s disease (HD) is a neurodegenerative
condition characterised by motor dysfunction
with involuntary movements and loss of
voluntary control, cognitive deterioration and
psychiatric problems. We report a 51-year-old
man with early HD who experienced stereotyped
episodes of repetitive, purposeless complex
movements and unresponsiveness. His
neurological examination was compatible with
HD as were all investigations. We diagnosed
psychogenic non-epileptic seizures. While
seizures are common in juvenile-onset HD, they
are no more prevalent in adult-onset HD than in
the general population. However,
neuropsychiatric symptoms are common in HD
and can involve a number of different
complaints. Patients may experience dissociative
attacks soon after manifesting a HD diagnosis.
Such episodes can be managed with patient and
carer education, cognitive behavioural therapy
and anxiolytic selective serotonin reuptake
inhibitors.
CASE REPORT
A 51-year-old man with early
Huntington’s disease (HD) was reviewed
at our multidisciplinary HD clinic after
developing stereotyped paroxysmal epi-
sodes of repetitive, purposeless complex
movements and unresponsiveness.
His mother and two brothers had HD.
He first attended our clinic at 51 years of
age after developing involuntary move-
ments and difficulty with complex tasks
at work. We confirmed the clinical diag-
nosis of early HD after a positive result
from HTT genetic testing. After this
initial appointment, he had informed his
employer about the diagnosis, who
offered him early retirement on medical
grounds—an event perceived by the
patient as a major emotionally stressful
life event.
A few months later, he started develop-
ing stereotyped episodes of repetitive,
purposeless complex movements and
unresponsiveness followed by transient
disorientation, emotional lability and
fatigue. His wife videotaped one episode
(see online supplementary video 1a). The
episodes were occurring about once
weekly and this frequency was stable over
time. There were no triggers or pro-
dromal symptoms, and each episode
lasted approximately 5 min. There was
no prior history of mental illness or
trauma. The episodes usually started with
him staring at or examining an object—
such as a spoon or a plastic box. After
30–60 s, repetitive purposeless complex
hand and upper limb movements ensued.
These were more complex than the mild,
fidgety movements of his HD-related
chorea. During the episodes, he was
awake but unresponsive to verbal stimuli.
At the end of the episode, the movements
waned and he started to answer to simple
commands. For about 10 min afterwards,
he was disorientated to place and person
with emotional lability and tiredness. He
made a complete recovery afterwards.
The patient consulted his general prac-
titioner who referred him to us concern-
ing that the attacks may be epileptic
seizures. Two months after the first
attack, we reviewed him; his neurological
examination between attacks was compat-
ible with HD (see online supplementary
video 1b) with no unexpected focal signs.
Routine and sleep-deprived electroence-
phalograms (EEGs) and MR neuroima-
ging were normal.
We diagnosed probable psychogenic
non-epileptic seizures according to the
International League Against Epilepsy
(ILAE) criteria1 on the basis of the pres-
ence of predisposing factors, compatible
semiology assessed by an experienced
neurologist in a video recording, exclu-
sion of an explanatory medical cause and
negative investigations, including interic-
tal EEG. We informed him of the diagno-
sis and the risk factors that had
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contributed to its development, counselled on
de-escalation techniques and gave citalopram for low
mood and anxiety. The episodes ceased and
24 months later, he remains event-free.
DISCUSSION
HD is a hereditary neurodegenerative condition
caused by a cytosine–adenine–guanine (CAG) repeat
expansion in the HTT gene on the short arm of
chromosome 4, with consequent production and accu-
mulation of mutant huntingtin protein, which causes
neuronal dysfunction and death.2 It is clinically char-
acterised by a triad of motor dysfunction with invol-
untary movements and loss of voluntary control,
cognitive deterioration and psychiatric problems.2
Seizures are common in juvenile-onset HD2 but are
no more prevalent in adult-onset HD than in the general
population. However, neuropsychiatric symptoms are
common in early HD and can involve several different
complaints,2 including dissociative phenomena.
In our experience, many patients experience func-
tional neurological symptoms soon after manifesting a
HD diagnosis—most likely because of increased
disease-related anxiety and the inevitable severe stress
that accompanies such a diagnosis. In the general
population, psychogenic non-epileptic seizures and
psychogenic movement disorders are among the most
frequent psychologically-mediated syndromes seen by
neurologists,3 and this is also our experience in the
HD clinic. It is often difficult to distinguish between
psychogenic movement disorders and psychogenic
non-epileptic seizures, since both share causative
factors and clinical features; some authors classify
both conditions under the same spectrum.3 In this
particular case, the altered higher mental function and
the complexity of the movements made psychogenic
non-epileptic seizures more likely.
Psychogenic non-epileptic seizures or dissociative sei-
zures occur in 10–20% of people diagnosed with epi-
lepsy.4 They can be clinically similar to any kind of
epileptic seizure but are of psychological origin rather
than being caused by hypersynchronous discharges in
the brain. Attacks that resemble complex partial seizures
are a relatively rare manifestation of psychogenic
non-epileptic seizures but, in our experience, patients
with HD can report any kind of epilepsy-like attack. It
remains to be seen whether complex partial seizure-like
attacks are more common in this population.
Psychogenic non-epileptic seizures are considered to be
an abnormal coping mechanism in the spectrum of dis-
sociation. Indeed, patients with this condition have
stronger connectivity between brain areas associated
with emotion (insula), executive (inferior frontal gyrus
and parietal cortex) and movement control (precentral
sulcus),5 a pattern also observed in conversion disorders.
Although psychogenic non-epileptic seizures are
most frequent in women in their 20s and 30s, they
can occur in anyone.1 There is a previous history of
psychological trauma or psychiatric co-morbidities in
approximately 70% of patients.1 Up to half of patients
have a precipitating life event.1 The semiology of psy-
chogenic non-epileptic seizures can resemble most
types of epileptic seizures but some aspects may
increase the clinical suspicion: triggering by psycho-
logical stress, long duration, fluctuating course, asyn-
chronous movements, pelvic thrusting, forced eye
closure, ictal crying, memory recall and signs of emo-
tional distress.1 6
The diagnostic gold standard is video EEG, with the
absence of ictal electroencephalographic abnormalities
before, during and after the attack.1 The use of this
technique is obligatory to make a documented diagno-
sis based on the ILAE criteria.1 Nevertheless, it is pos-
sible to establish the diagnosis with a lower degree of
certainty. A clinically established diagnosis should be
made when a conventional ictal EEG detects no
abnormalities and the semiology is compatible with
psychogenic non-epileptic seizures; a normal interictal
EEG and a clinically witnessed event or clinically
reviewed video-recording of an event suffice to allow
a probable diagnosis; and finally, at the lower end of
diagnostic certainty, a possible diagnosis needs a
normal interictal EEG and a witness or self-reported
description of a compatible event.1
These non-epileptic attacks can have adverse
quality-of-life consequences and a high rate of recur-
rence.7 Thankfully, early and accurate recognition of
psychogenic non-epileptic seizures improves the prog-
nosis.8 The treatment plan should encompass discuss-
ing and explaining the diagnosis to the patient and
carers, withdrawal of antiepileptic drugs with special
attention to discontinuation syndromes, and psychi-
atric and/or psychological interventions.6
Key points
▸ Huntington’s disease (HD) is a hereditary neurode-
generative condition caused by a cytosine–adenine–
guanine repeat expansion, characterised by motor
dysfunction, cognitive deterioration and psychiatric
problems.
▸ Epileptic seizures are a common feature of juvenile-
onset HD.
▸ Seizures are no more prevalent in adult-onset HD
than in the general population, but anxiety phenom-
ena are very common in HD and can produce dis-
sociative phenomena that clinically mimic epileptic
events.
▸ Many patients experience functional neurological
symptoms soon after manifesting a HD diagnosis.
▸ Non-epileptic seizures should be managed with
patient and carer education, withdrawal from antiepi-
leptic drugs, and psychiatric and/or psychological
interventions.
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